Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

(MENAFN- GlobeNewsWire - Nasdaq) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media ...

The SCIEX Echo MS+ and ZenoTOF 8600 systems redefine screening with one-second acoustic sampling and 10x sensitivity. By removing LC bottlenecks, this label-free platform accelerates drug discovery ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

New NASA-level software framework reproduces DUT vs ΛCDM results, resolving Hubble and growth tensions with Δχ² = ...

SaltLight returned 30.78% in 2025 and launched a new global fund while increasing its NVIDIA position. Read the full analysis for more details.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services ...

For investors tracking the pioneering single-cell biology firm Berkeley Lights, the search now leads to a different corporate entity. The company's journey as a ...